AIM/RUA (AIM/RUA)

London Stock Exchange AIM: AIM/RUA · GBX

GBX 27.1

-0.40 (-1.4%)· Recorded snapshot

Market cap	16.8M
Revenue (ttm)	4.6M
Net income (ttm)	281.7K
EPS (ttm)	GBX 0.00
Shares out	62.1M
P/E (trailing)	59.7x
Volume	138,436
Beta	1.00

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 4.6M
Net income (ttm): 281.7K
EPS (ttm): GBX 0.00
P/E (trailing): 59.7x
Market cap: 16.8M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E59.7

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC2.3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

S&P 500+0.8%

Nasdaq Composite-1.0%

Dow Jones Industrial Average+1.9%

Russell 2000+0.3%

All AIM/RUA indicators

Market & fundamental data

Available fields

203

Groups with data

Currency

GBP

Showing 203 of 203 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	GBP
Country	United Kingdom
Country code	UK
Earnings date	2026-12-11
Employees	59
Employees change	19
Employees growth	47.5%
Enterprise value	GBX 15.1M
Exchange	London Stock Exchange AIM
Financial currency	GBP
Financial report date	2026-03-31
First seen	2026-05-10
Fiscal year end	September
Founded	1996
Industry	Medical Devices
Is primary listing	Yes
ISIN number	GB0033360586
Last earnings date	2025-12-11
Last refreshed	2026-10-28
Last stock split date	2003-09-01
Last stock split type	Reverse
Market cap	GBX 16.8M
Next earnings date	2026-12-11
Price	GBX 27.10
Price currency	GBX
Sector	Healthcare
SIC code	3842
Stock price date	2026-10-28
Symbol	aim/RUA
Website	https://rualifesciences.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	1.67%
EV/Earnings	54.64x
EV/EBIT	113.45x
EV/EBITDA	26.77x
EV/Sales	3.33x
FCF / EV yield	-6.63%
FCF yield	-5.98%
Graham number	10.731
Graham upside	-61.26%
Industry forward P/E	13.63x
Industry P/E	21.46x
P/B ratio	2.42x
P/E ratio	59.72x
P/S ratio	3.7x
Price / tangible book value	2.67x
Price/EBITDA ratio	29.68x
Sector forward P/E	14.49x
Sector P/E	22.58x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	2.94%
EBITDA margin	12.45%
Effective tax rate	7.98%
Gross margin	78.21%
Operating margin	2.94%
Pretax margin	6.51%
Profit margin	6.1%
Profit per employee	GBX 4,774
Revenue per employee	GBX 78,260
ROCE	1.75%
ROIC	2.35%
SBC / revenue	2.47%
Tax / revenue	0.52%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	1
EPS growth years	0
Gross profit growth	4.48%
Gross profit growth (Q)	62.17%
Gross profit growth 3Y	31.21%
Gross profit growth 5Y	23.29%
Net income growth quarters	1
Net income growth years	0
Revenue growth	3.54%
Revenue growth (Q)	6.1%
Revenue growth (QoQ)	6.1%
Revenue growth 10Y	22.14%
Revenue growth 3Y	31.64%
Revenue growth 5Y	24.13%
Revenue growth years	8

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	GBX -121,333
Depreciation and amortization	GBX 439,334
EBIT	GBX 135,667
EBITDA	GBX 575,001
EPS	GBX 0.00
FCF per share	GBX -0.02
Financing cash flow	GBX -316,000
Free cash flow	GBX -1M
Free cash flow minus SBC	GBX -1.1M
Gross profit	GBX 3.6M
Income taxes	GBX 24,000
Investing cash flow	GBX 112,000
Net borrowing	GBX -367,334
Net cash flow	GBX -1.1M
Net income	GBX 281,667
Operating cash flow minus SBC	GBX -1M
Operating income	GBX 135,667
Revenue	GBX 4.6M
Stock-based compensation	GBX 114,000

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	0.8
Book value per share	GBX 0.11
Debt / EBITDA	1.13
Debt / equity	0.09
Goodwill	GBX 301,000
Long-term assets	GBX 3.5M
Long-term liabilities	GBX 700,000
Net cash (debt)	GBX 1.7M
Net cash / market cap	10.04%
Net cash growth	-34.15%
Net debt / EBITDA	-2.98
Net debt / equity	-0.24
Piotroski F-Score	3
Property, plant and equipment	GBX 2.9M
Shareholders' equity	GBX 7M
Tangible book value	GBX 6.4M
Tangible book value per share	GBX 0.10
Total assets	GBX 8.6M
Total cash	GBX 2.4M
Total debt	GBX 651,000
Total liabilities	GBX 1.6M
WACC	9.38%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	GBX 5.1M
Current liabilities	GBX 860,000
Current ratio	5.92
Net working capital	GBX 2M
Quick ratio	4.44
Working capital	GBX 4.2M
Working capital turnover	1

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	32.2%
10Y return CAGR	3.37%
10Y total return	39.29%
150-day SMA	GBX 22.96
15Y price change	-85.96%
15Y return CAGR	-11.96%
15Y total return	-85.2%
1D price change	-1.45%
1M price change	-9.67%
1M total return	-9.67%
1W price change	2.26%
1W total return	2.26%
1Y price change	143.05%
1Y return CAGR	143.2%
1Y total return	143.05%
20-day SMA	GBX 28.23
200-day SMA	GBX 20.70
20Y price change	-94.17%
20Y return CAGR	-13.02%
20Y total return	-93.86%
3M price change	10.61%
3M total return	10.61%
3Y price change	121.22%
3Y return CAGR	30.29%
3Y total return	121.22%
50-day SMA	GBX 27.95
50-day SMA vs 200-day SMA	50over200
52-week high	GBX 31.00
52-week high date	2026-10-13
52-week low	GBX 10.50
52-week low date	2025-10-28
5Y price change	-82.4%
5Y return CAGR	-29.36%
5Y total return	-82.4%
6M price change	44.53%
6M total return	44.53%
All-time high	GBX 10,332.50
All-time high date	2000-11-09
All-time low	GBX 8.00
All-time low date	2017-03-24
Average true range (ATR)	GBX 1.41
Average volume	117.2K
Beta (1Y)	0.64
Beta (2Y)	0.36
Beta (5Y)	1
Change from 52-week high	-12.58%
Change from 52-week low	158.1%
Change from all-time high	-99.74%
Change from all-time low	238.75%
Change from open	-1.09%
Day's gap	-0.36%
Dollar volume	GBX 3.8M
High price	GBX 27.84
Low price	GBX 27.10
Monthly RSI	62.07
Open price	GBX 27.40
Position in 52-week range	0%
Previous close	GBX 27.50
Price vs 150-day SMA	18.06%
Price vs 20-day SMA	-3.99%
Price vs 200-day SMA	30.89%
Price vs 50-day SMA	-3.04%
Relative volume	1.18
RSI	41.8
Sharpe ratio	1.87
Sharpe ratio (3Y)	0.59
Sharpe ratio (5Y)	-0.18
Sortino ratio	3.47
Sortino ratio (3Y)	1.14
Sortino ratio (5Y)	-0.2
Volume	138.4K
Weekly RSI	59.6
YTD price change	93.57%
YTD total return	93.57%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	50.4M
Shares change (QoQ)	0%
Shares held by insiders	13.87%
Shares held by institutions	56.34%
Shares outstanding	62.1M

Deeper analysis on AIM/RUA

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this AIM/RUA report

Is a complete AIM/RUA research report available?

No complete published report is available for aim/RUA (AIM/RUA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap

16.8M

Revenue (ttm)

4.6M

Net income (ttm)

281.7K

EPS (ttm)

GBX 0.00

Shares out

62.1M

P/E (trailing)

59.7x

Volume

138,436

Beta

1.00

Metric

Value

Amount currency

GBP

Country

United Kingdom

Country code

Earnings date

2026-12-11

Employees

Employees change

Employees growth

47.5%

Enterprise value

GBX 15.1M

Exchange

London Stock Exchange AIM

Financial currency

GBP

Financial report date

2026-03-31

First seen

2026-05-10

Fiscal year end

September

Founded

1996

Industry

Medical Devices

Is primary listing

Yes

ISIN number

GB0033360586

Last earnings date

2025-12-11

Last refreshed

2026-10-28

Last stock split date

2003-09-01

Last stock split type

Reverse

Market cap

GBX 16.8M

Next earnings date

2026-12-11

Price

GBX 27.10

Price currency

GBX

Sector

Healthcare

SIC code

3842

Stock price date

2026-10-28

Symbol

aim/RUA

Website

https://rualifesciences.com

Metric

Value

Earnings yield

1.67%

EV/Earnings

54.64x

EV/EBIT

113.45x

EV/EBITDA

26.77x

EV/Sales

3.33x

FCF / EV yield

-6.63%

FCF yield

-5.98%

Graham number

10.731

Graham upside

-61.26%

Industry forward P/E

13.63x

Industry P/E

21.46x

P/B ratio

2.42x

P/E ratio

59.72x

P/S ratio

3.7x

Price / tangible book value

2.67x

Price/EBITDA ratio

29.68x

Sector forward P/E

14.49x

Sector P/E

22.58x

Metric

Value

EBIT margin

2.94%

EBITDA margin

12.45%

Effective tax rate

7.98%

Gross margin

78.21%

Operating margin

2.94%

Pretax margin

6.51%

Profit margin

6.1%

Profit per employee

GBX 4,774

Revenue per employee

GBX 78,260

ROCE

1.75%

ROIC

2.35%

SBC / revenue

2.47%

Tax / revenue

0.52%

Metric

Value

EPS growth quarters

EPS growth years

Gross profit growth

4.48%

Gross profit growth (Q)

62.17%

Gross profit growth 3Y

31.21%

Gross profit growth 5Y

23.29%

Net income growth quarters

Net income growth years

Revenue growth

3.54%

Revenue growth (Q)

6.1%

Revenue growth (QoQ)

6.1%

Revenue growth 10Y

22.14%

Revenue growth 3Y

31.64%

Revenue growth 5Y

24.13%

Revenue growth years

Metric

Value

Capital expenditures

GBX -121,333

Depreciation and amortization

GBX 439,334

EBIT

GBX 135,667

EBITDA

GBX 575,001

EPS

GBX 0.00

FCF per share

GBX -0.02

Financing cash flow

GBX -316,000

Free cash flow

GBX -1M

Free cash flow minus SBC

GBX -1.1M

Gross profit

GBX 3.6M

Income taxes

GBX 24,000

Investing cash flow

GBX 112,000

Net borrowing

GBX -367,334

Net cash flow

GBX -1.1M

Net income

GBX 281,667

Operating cash flow minus SBC

GBX -1M

Operating income

GBX 135,667

Revenue

GBX 4.6M

Stock-based compensation

GBX 114,000

Metric

Value

Altman Z-Score

0.8

Book value per share

GBX 0.11

Debt / EBITDA

1.13

Debt / equity

0.09

Goodwill

GBX 301,000

Long-term assets

GBX 3.5M

Long-term liabilities

GBX 700,000

Net cash (debt)

GBX 1.7M

Net cash / market cap

10.04%

Net cash growth

-34.15%

Net debt / EBITDA

-2.98

Net debt / equity

-0.24

Piotroski F-Score

Property, plant and equipment

GBX 2.9M

Shareholders' equity

GBX 7M

Tangible book value

GBX 6.4M

Tangible book value per share

GBX 0.10

Total assets

GBX 8.6M

Total cash

GBX 2.4M

Total debt

GBX 651,000

Total liabilities

GBX 1.6M

WACC

9.38%

Metric

Value

Current assets

GBX 5.1M

Current liabilities

GBX 860,000

Current ratio

5.92

Net working capital

GBX 2M

Quick ratio

4.44

Working capital

GBX 4.2M

Working capital turnover

Metric

Value

10Y price change

32.2%

10Y return CAGR

3.37%

10Y total return

39.29%

150-day SMA

GBX 22.96

15Y price change

-85.96%

15Y return CAGR

-11.96%

15Y total return

-85.2%

1D price change

-1.45%

1M price change

-9.67%

1M total return

-9.67%

1W price change

2.26%

1W total return

2.26%

1Y price change

143.05%

1Y return CAGR

143.2%

1Y total return

143.05%

20-day SMA

GBX 28.23

200-day SMA

GBX 20.70

20Y price change

-94.17%

20Y return CAGR

-13.02%

20Y total return

-93.86%

3M price change

10.61%

3M total return

10.61%

3Y price change

121.22%

3Y return CAGR

30.29%

3Y total return

121.22%

50-day SMA

GBX 27.95

50-day SMA vs 200-day SMA

50over200

52-week high

GBX 31.00

52-week high date

2026-10-13

52-week low

GBX 10.50

52-week low date

2025-10-28

5Y price change

-82.4%

5Y return CAGR

-29.36%

5Y total return

-82.4%

6M price change

44.53%

6M total return

44.53%

All-time high

GBX 10,332.50

All-time high date

2000-11-09

All-time low

GBX 8.00

All-time low date

2017-03-24

Average true range (ATR)

GBX 1.41

Average volume

117.2K

Beta (1Y)

0.64

Beta (2Y)

0.36

Beta (5Y)

Change from 52-week high

-12.58%

Change from 52-week low

158.1%

Change from all-time high

-99.74%

Change from all-time low

238.75%

Change from open

-1.09%

Day's gap

-0.36%

Dollar volume

GBX 3.8M

High price

GBX 27.84

Low price

GBX 27.10

Monthly RSI

62.07

Open price

GBX 27.40

Position in 52-week range

Previous close

GBX 27.50

Price vs 150-day SMA

18.06%

Price vs 20-day SMA

-3.99%

Price vs 200-day SMA

30.89%

Price vs 50-day SMA

-3.04%

Relative volume

1.18

RSI

41.8

Sharpe ratio

1.87

Sharpe ratio (3Y)

0.59

Sharpe ratio (5Y)

-0.18

Sortino ratio

3.47

Sortino ratio (3Y)

1.14

Sortino ratio (5Y)

-0.2

Volume

138.4K

Weekly RSI

59.6

YTD price change

93.57%

YTD total return

93.57%

Metric

Value

Float

50.4M

Shares change (QoQ)

Shares held by insiders

13.87%

Shares held by institutions

56.34%

Shares outstanding

62.1M

AIM/RUA (AIM/RUA)

Price

Financial snapshot

Fair-value bridge

Latest news · AIM/RUA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AIM/RUA indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Performance and technicals

Ownership and float

Deeper analysis on AIM/RUA

Frequently asked questions

AIM/RUA (AIM/RUA)

Price

Financial snapshot

Fair-value bridge

Latest news · AIM/RUA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AIM/RUA indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Performance and technicals

Ownership and float

Deeper analysis on AIM/RUA

Frequently asked questions